Para preguntas en general por favor contacte a nuestro Servicio de Atención al Cliente:
Merck KGaA
Frankfurter Str. 250
64293 Darmstadt
Germany
Teléfono: +49 6151 72-0
Fax: +49 6151 72 2000
15 febrero 2012
cargando
A cell-permeable antitumor antibiotic. A stereoisomer of Doxorubicin (Cat. No. 324380) that exhibits reduced cardiotoxicity. Its antitumor actions are mediated by targeting topoisomerase II.
| Información sobre producto | |||
|---|---|---|---|
| Form | Orange-red solid | ||
| Protect from Light | Si | ||
| Hygrocopic | Si | ||
| Cell permeable | Si | ||
| Purity | ≥95% by HPLC | ||
| Fórmula químico | C27H29NO11 · HCl | ||
| RTECS | QI9295750 | ||
| Número CAS | 56390-09-1 | ||
| Merck USA index | 14, 3623 | ||
| Almacenar y enviar información | |||
|---|---|---|---|
| Categoría de alamacenamiento | +2°C to +8°C | ||
| Ship |
Ambient Temperature Only
Harmful & Carcinogenic / Teratogenic |
||
| Información de seguridad | |||
|---|---|---|---|
| Frase S |
S: 22-36 |
||
| Frase R |
R: 20/21/22-40 |
||
